MARKET

BLRX

BLRX

Biolinerx
NASDAQ
3.165
+0.050
+1.61%
After Hours: 3.180 +0.015 +0.47% 16:10 06/26 EDT
OPEN
3.070
PREV CLOSE
3.115
HIGH
3.290
LOW
3.070
VOLUME
6.02K
TURNOVER
--
52 WEEK HIGH
5.06
52 WEEK LOW
2.150
MARKET CAP
13.77M
P/E (TTM)
-6.4173
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BLRX last week (0615-0619)?
Weekly Report · 4d ago
Weekly Report: what happened at BLRX last week (0608-0612)?
Weekly Report · 06/15 09:54
BioLineRx Earnings Call: Pipeline Momentum, Profit Squeeze
TipRanks · 06/09 00:01
Weekly Report: what happened at BLRX last week (0601-0605)?
Weekly Report · 06/08 09:51
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 06/04 12:05
JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)
TipRanks · 06/02 12:41
Analysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)
TipRanks · 06/02 12:41
Weekly Report: what happened at BLRX last week (0525-0529)?
Weekly Report · 06/01 09:54
More
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Webull offers BioLine RX Ltd - ADR stock information, including NASDAQ: BLRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLRX stock methods without spending real money on the virtual paper trading platform.